Bristol Myers dips on ‘confounding’ lung drug results
Only the lower of two tested doses of the idiopathic pulmonary fibrosis drug admilparant met the trial’s main objective, adding to analyst questions about the therapy’s prospects.
Bristol Myers Squibb (BMY) stock news
Every headline mentioning Bristol Myers Squibb from Yahoo Finance and BioPharma Dive over the last 30 days, each scored for sentiment and importance. Updated automatically through the trading day.
Headlines2last 7 days · 3 in 30 days
Sentiment, 30 days
0 positive2 neutral1 negative
Latest headlineMon 12 Oct, 15:35 UTCHealthcare
Latest BMY headlines
Monday, 12 October 2026
Wednesday, 7 October 2026
2 High-Yield Stocks to Buy in October (Hint: Bristol Myers Squibb Is One)
If you are looking for yield and can think long-term, you'll want to consider Bristol Myers Squibb and Realty Income today.
Saturday, 3 October 2026
Bristol Myers Squibb Now Trades at Only 9.4X Forward Earnings -- Is This Value Stock a Buy?
Bristol Myers Squibb isn't a growth stock, but it may offer something to bargain hunters and dividend seekers.